AVELOX

This brand name is authorized in Austria, Cyprus, Ecuador, Estonia, Finland, Hong Kong, Ireland, Japan, Lithuania, Malta, Mexico, Nigeria, New Zealand, Romania, Singapore, Turkey, United Kingdom

Active ingredients

The drug AVELOX contains one active pharmaceutical ingredient (API):

1 Moxifloxacin UNII C53598599T - MOXIFLOXACIN HYDROCHLORIDE

Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. Read about Moxifloxacin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AVELOX Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
AVELOX Solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01MA14	Moxifloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29379-09-10, 29685-03-11
Country: EE	Ravimiamet	Identifier(s): 1154551, 1154562, 1154573, 1154607, 1154618, 1154629, 1154630, 1154641, 1154652, 1154663, 1154674, 1154685
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 385813, 492411
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 104964, 167520, 167521, 175337, 185459, 43608
Country: HK	Department of Health Drug Office	Identifier(s): 46950, 50810
Country: IE	Health Products Regulatory Authority	Identifier(s): 53501, 53507, 53525
Country: JP	医薬品医療機器総合機構	Identifier(s): 6241016F1028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1016709, 1016710, 1016711, 1016712, 1018689, 1018690, 1018691, 1055157, 1055158, 1055159, 1055160, 1055161, 1055162, 1085581, 1085935
Country: MT	Medicines Authority	Identifier(s): MA639/01602
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 174M2001, 590M98
Country: NG	Registered Drug Product Database	Identifier(s): A4-3297
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 10185, 9057
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63876001, W63876002, W63876003, W63876004, W63876007, W63876008, W63876009, W63876010, W63876011, W63876012, W63876015, W63876016, W63876017, W63876018, W63876020, W63876021, W63876022, W63876024, W63876025, W63876026, W63876027, W63876028, W63876029, W63876030, W63876031, W63877001, W63877002, W63877003, W63877004
Country: SG	Health Sciences Authority	Identifier(s): 11351P, 11971P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546090129, 8699546090372, 8699546090433